Air Sanitization Solutions | Healthcare | Aerobiotix

SOLUTIONS | HEALTHCARE

Reduce SSI, Protect Patients & Staff

The Aerobiotix Illuvia HUAIRS (HEPA-Ultraviolet Nonturbulent Air Recirculation System) reduces the risk of surgical site infection (SSI) and improves environmental safety for patients and clinicians.

Air Sanitization Solutions - Bug
Operating room air is full of dangerous contaminants, including:

  • Airborne bacteria – can cause surgical site infection1
    • 80% of bacteria found in the wound after surgery comes
      from the air2
  • Surgical smoke particles – contains hazardous chemicals
    • O.R. staff are exposed to the equivalent of 27-30 cigarettes
      daily3
  • Infectious aerosols – shed by patients and staff and released
    through aerosol-generating procedures, surgical smoke4,5
    • Expose staff and patients to SARS-CoV-2, C-diff., TB, MRSA
  • Volatile organic compounds (VOCs) – classified as hazardous
    by OSHA
Air Sanitization Solutions - Bug
Operating room air is full of dangerous contaminants, including:

  • Airborne bacteria – can cause surgical site infection1
    • 80% of bacteria found in the wound after surgery comes
      from the air2
  • Surgical smoke particles – contains hazardous chemicals
    • O.R. staff are exposed to the equivalent of 27-30 cigarettes
      daily3
  • Infectious aerosols – shed by patients and staff and released through aerosol-generating procedures, surgical smoke4,5
    • Expose staff and patients to SARS-CoV-2, C-diff., TB, MRSA
  • Volatile organic compounds (VOCs) – classified as hazardous by OSHA

Isn’t HVAC Enough?

The air coming into your building through the HVAC system is clean when it enters the room. The air isn’t the issue—people are.

“The microbial level in operating room air is directly proportional to the number of people moving in the room.”6 – CDC

As staff members move through the O.R., they shed viruses, bacteria, and spores. Current interventions have limitations:

  • HVAC systems are not designed to deal with short bursts of bioaerosols (from people).
  • Standard room air exchanges are not enough for today’s busy O.R.s.
  • Facemasks alone do not prevent microbial shedding.
  • Central laminar flow systems neglect the areas outside of the central zone.

“Even the most robust HVAC system cannot control all airflows and completely prevent dissemination of an infectious aerosol or disease transmission by droplets or aerosols.”7 – ASHRAE, 2020

Illuvia® HUAIRS

Increasing airflow or using HEPA filters can improve air quality but won’t eliminate germs in the air like Illuvia. The nonturbulent device uses shielded UVC germicidal light, HEPA filtration, and a proprietary pre-filter cartridge to reduce overall aerosol burden by 70%.8

  • Proven: Inactivates 99.9% of viruses, bacteria, and spores (including SARS-CoV-2, C-diff., TB, MRSA) in a single pass.9
  • FDA-Regulated: Class II FDA medical device.
  • Continuous: Runs during procedures to protect at point of care.
  • Complementary: Actively eliminates live contaminants and runs continuously to support the work of HVAC and other solutions.
  • Data-Driven: Measures reduction of air contaminants, enabling proactive air quality management.

Use Illuvia to:

  • Reduce risk of surgical site infections (SSI)10, extended length of stay (LOS), and readmission
  • Increase environmental safety for patients and clinicians
  • Increase efficiency through faster turnover (due to reduced cleaning time)
  • Increase profitability through efficiency, reduced infections, and improved reputation

Proactive Air Management

Illuvia features an integrated particle counter that enables you to monitor and manage the amount of airborne contamination in the operating room.

The chart in this section shows an example of control air quality in the operating room vs. air quality with the Illuvia in use.

See the results at your facility! Contact us to request a complimentary Air Quality Assessment of your operating rooms.

(Source: Data on file, Aerobiotix)

A Proven Solution

Published studies have shown that Illuvia:

  • Inactivates 99.9% of bacteria, viruses, and spores in the air.9
  • Reduces airborne bacteria levels during surgery by 72%, creating a safer environment for patients and staff.11
  • Can reduce the risk of infection during surgery.12
  • Can help reduce surface contamination by 51%.13
  • Can reduce particles arising from smoke plume during surgical
    procedures.14
  • Can reduce SARS-CoV-2 bioaerosols below detectable levels.15

Events

national-association-of-spine-surgeons-aerobiotix

AORN Global Surgical Conference & Expo

New Orleans, LA March 19-23, 2022
read more

awhonn

AAOS Annual Meeting

Chicago, IL March 22-26, 2022
read more

national-association-of-spine-surgeons-aerobiotix

OR Manager Conference

Chicago, Il. October 20-22.
read more

Frequently Asked Questions

How does Illuvia work?
  • A pre-filter cartridge first captures larger particles to ensure optimum efficiency of the system.
  • A proprietary photolytic chamber slows the travel of particles, providing sufficient time for internal ultraviolet light to inactivate them.
  • The remaining particles, now inactivated, move through a medical-grade HEPA filter to trap them from returning to the air.
  • This technology provides a pathogen elimination rate of 99%.
How much space does Illuvia need?
  • Illuvia is engineered for the smallest possible environmental impact.
  • Footprint: 18” x 18”
Is Illuvia loud?
  • Illuvia makes a consistent white noise-like sound.
  • The noise produced from 450 CFM of unit air movement is quite small compared to 2000 CFM typically originating from overhead air ducts.
Is Illuvia a UV robot?
  • Illuvia is not a UV robot; it is a nonturbulent ultraclean surgical air system.
  • UV robots perform one-time disinfection of unoccupied room surfaces. Once the room is occupied again, it becomes re-contaminated. Illuvia performs continuous air sanitization in occupied rooms.
Does Illuvia Affect Airflow or Positive Pressure?
  • Illuvia is specifically designed for use in the operating room. It is nonturbulent.
  • Illuvia has a one-to-one air ratio, meaning the same amount of air that goes in comes out. It does not affect airflow.
  • The device is placed so it does not block wall ducts.
  • The device moves at high volume but low velocity and is designed to not disrupt airflow near the patient.
Is there a warranty?
  • Yes, Illuvia is warranted to be free of defects in material, manufacture, and design for a period of three years.
How safe are UVGI (ultraviolet germicidal irradiation) products?

Unlike many UVGI products currently available, Illuvia uses shielded ultraviolet light (lamps contained within the units), so there is no exposure of ultraviolet light to people. Therefore, our products are safe to use in occupied spaces.

UVGI lamps have been used for many decades in the healthcare industry.
UVC treatment is a proven method for sanitizing air, water, and nonporous surfaces.

What do regulatory organizations say about using HEPA and UVGI to combat SARS-CoV-2?

The American Association of Hip & Knee Surgeons (AAHKS) says:
“Install filters that are able to remove aerosol and droplets, such as HEPA filters. Consideration should be given to the use of portable HEPA filter systems that can remove viral particles from the operating room air without converting to a negative pressure environment.”16

The American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) recommends:

  • Use portable, free-standing high-efficiency particulate air (HEPA) filters.
  • Use UVGI.
  • Only use air cleaners for which evidence of effectiveness and safety is clear. For more information from ASHRAE on the benefits of HEPA and UVGI, refer to the Position Document on Infectious Aerosols (April 14, 2020).

The Occupational Health and Safety Administration (OSHA) recommends:

Has Illuvia been tested for effectiveness?

Yes, this technology has been tested by independent laboratories RTI, NIOHIM, and Battelle Institute. It has been tested with MS2, Mycobacterium tuberculosis, and SARS-CoV-2. For test documents, please contact info@aerobiotix.com.

Many peer-reviewed studies and whitepapers also show the product’s efficacy. See “A Proven Solution” above.

What are the maintenance needs of Illuvia?
  • Cleaning: Wipe down exterior of the unit with an EPA-registered disinfectant.
  • Pre-filter Cartridge Replacement:
    • Daily
  • HEPA Filter Replacement/UV Lamp Replacement:
    • Performed by Aerobiotix representative.

Ready to Learn More?

Contact us today to learn more about how the Aerobiotix Illuvia can help you reduce surgical site infections and improve patient and staff safety in the O.R.

Contact Us

Ready to Learn More?

Contact us today to learn more about how the Aerobiotix Illuvia can help you reduce surgical site infections and improve patient and staff safety in the O.R.

Contact Us

Powered by Powered by Aerobiotix

Aerobiotix is a leading manufacturer of environmental management devices for efficient biological elimination of airborne viruses, bacteria and spores. Aerobiotix products are used in hospitals and other healthcare facilities around the world.

Download AeroCure 200 Specs

Download AeroCure Vac Specs

Download Illuvia®Sense Specs

Download AeroCure 200 Specs 📞 +1-888-978-7087

Download AeroCure Vac Specs 📞 +1-888-978-7087

Download Illuvia®Sense Specs 📞 +1-888-978-7087

JASON-TODD-VP-SALES-AEROBIOTIX

JASON TODD

Vice President of Global Sales

Jason leads our global sales team and brings over 18 years of Medical Device experience to Aerobiotix. Jason has led top performing National and Regional Sales teams, selling disruptive technology in the Cardiovascular space with Getinge, Surgical Robotics at Hansen Medical and most recently in the Biologics space with Axogen. Jason received his Bachelor of Science Degree from the University of Indianapolis.

MELISSA-GIETZEN-VP-GLOBAL-MARKETING-AEROBIOTIX

MELISSA GIETZEN, MBA

Vice President of Global Marketing

Melissa Gietzen, MBA is a highly skilled strategic marketing professional with over 20 years’ experience in the healthcare industry. She has significant expertise in strategic planning, capital budgeting, service improvement projects, and creating strong successful brands in the orthopedic, cardiac & ophthalmology markets. Melissa holds a undergraduate degree in Management and Organization Development and a masters degree in Business Administration.

DAVID KIRSCHMAN, M.D. President and CEO

DAVID KIRSCHMAN, M.D.

President and CEO

The founder and CEO is David Kirschman, M.D., a former physician with extensive experience as CEO, Director, Chief Scientific Officer and operator in the orthopedic and biologic medical device space. Dr. Kirschman holds 55 issued US Patents for a wide range of medical devices. He received his BS in Biological Science cum laude from Colorado State University and M.D. from University of Colorado School of Medicine.

GREGORY CARROLL PH.D. Director Scientific Affairs

GREGORY CARROLL PH.D.

Director Scientific Affairs

Dr. Carroll has extensive experience in ultraviolet and photonic science. Prior to joining Aerobiotix, he led the research and development group at Sunstar Engineering. He has a Ph.D. in chemistry from Columbia University and did his postdoctoral fellowship under Nobel laureate Prof. Ben Feringa at the University of Groningen, Netherlands, and Lawrence Berkeley National Laboratory.

TONY EMBREE Chief Commercial Officer

TONY EMBREE

Chief Commercial Officer

Tony leads our global sales organization and commercialization strategy. Prior joining Aerobiotix, he was Senior Manager of Strategy at Stryker. He has led sales and marketing teams in multiple organizations including SurgiCount Medical, part of Patient Safety Technologies, INC (PSTX) as it expanded from 8 hospitals in 2008 to user base of 330 hospitals at time of acquisition in 2013.

COURTNEY ADAMS, Ph.D. VP of Clinical and Medical Affairs

COURTNEY ADAMS, Ph.D.

VP of Clinical and Medical Affairs

Dr. Adams leads our global clinical research and education initiatives as well as developing key opinion leaders to support our clinical mission. Prior to joining Aerobiotix, she held leading research and medical affairs roles at Biogen, Axogen, and MedPace. Dr. Adams holds Ph.D. in Pharmacology from University of Cincinnati.

ANTHONY DEFALCO Vice President of Engineering

ANTHONY DEFALCO

Vice President of Engineering

Anthony is a topflight medical device product development engineer and leader, experienced in the development and implementation of orthopedic, environmental, and electromechanical systems.

NATHAN UTZ Vice President of Client Services

NATHAN UTZ

Vice President of Client Services

Nathan brings a high level of commitment to servicing and building client relations. Nathan has previously held leadership roles in the medical device industry.

MICHAEL SCHMITZ Chief Financial Officer

MICHAEL SCHMITZ

Chief Financial Officer

Mr. Schmitz is a highly experienced financial practitioner with financial leadership roles in diverse industries including manufacturing and technology as well as a background in public accounting. He received his BS in accounting, cum laude, from the Miami University of Ohio. Mr. Schmitz is a certified public accountant and certified management accountant.